In this manuscript we summarize the role of chronic stress as a potential trigger factor for Parkinson's disease. Underlying mechanisms and stress-induced changes to the neuronal networks have been highlighted. Examples of stress induced reversible symptoms that resemble parkinsonism in humans and in animal models raise the question whether emotional stress can cause striatal degeneration in susceptible patients. A Pubmed literature review searching for the terms ‘Stress’, ‘Distress and Parkinson's disease’, 'Emotional Distress and Parkinson's disease’, ‘Stress and Parkinson's disease’, ‘Prodromal Parkinson's disease’, ‘Non motor symptoms and Parkinson's disease’, ‘Paradoxical kinesia’, ‘Psychogenic parkinsonism’, ‘Functional somatic syndromes’, ‘Chronic fatigue syndrome’, ‘Irritable bowel syndrome’, ‘Fibromyalgia’, ‘Dopamine and fibromyalgia’, ‘Dopamine and chronic fatigue syndrome’ and ‘Dopamine and irritable bowel syndrome’ was carried out until April 2013. Articles were also identified through searches of the authors’ own files. Only papers published in English were reviewed. The final reference list was generated on the basis of originality and relevance to the broad scope of this viewpoint.
- PARKINSON'S DISEASE
- SOMATISATION DISORDER
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Can emotional stress trigger Parkinson's disease (PD)? This idea is compelling but not new. More than 100 years ago, Gowers wrote that prolonged anxiety and emotional shock are ‘the most common antecedents of Parkinson's disease’ and advised his patients to refrain from ‘all causes of mental strain and of physical exhaustion’. Extreme psychological stress, such as the holocaust, has been associated with PD1 and in some studies ex-prisoners of war had a significantly higher incidence of developing PD several decades after their release.2 More recently, several authors have speculated about the role of emotional stress in PD.3–5
Here, we hypothesise that chronic stress can cause nigrostriatal degeneration in susceptible individuals, who have impairment in stress coping mechanisms. Further, we speculate that the non-motor symptoms in the prodromal phase of PD resemble those seen in patients with functional somatic syndromes. We emphasise that we are putting forward a theory for consideration and not claiming the evidence is definitive.
We define stress according to the Oxford English Dictionary as ‘a state of mental or emotional strain or tension resulting from adverse or demanding circumstances’.6
Short self-limiting stressors evoke ‘fight and flight’ catecholaminergic reactions, via the sympathetic nervous system, and can be beneficial.7 Chronic stress, on the other hand, either due to major life events or due to minor but frequent ‘irritations and frustrations’ causes a prolonged activation of the hypothalamic–pituitary–adrenal (HPA)8 axis and triggers ‘alleostatic load’, a failure of adequate coping mechanisms to reduce stress.9 This can cause ‘lifestyle diseases’ such as type 2 diabetes mellitus, gastric ulcers or hypertension.10
A convincing link between chronic stress and neurodegeneration has been now established in patients with Alzheimer's disease. Emotionally stressed patients have a 2.7% higher risk of developing the disease and stressed dementia patients have a more rapid disease progression.11
A recent case report suggested that major stress may have triggered PD in a young woman12 and stress-induced striatal damage, with subsequent worsening of motor symptoms has been also found in several animal models of PD.
Elevated glucocorticoid levels in rodent models worsened motor performance and higher corticosterone levels led to a greater permanent loss of nigral neurons.4 6-Hydroxydopamine (6-OHDA)-lesioned rats moved more slowly, froze more often and became rigid when challenged with stressors but reverted to normal when left alone in their home cage.13 Foot shock, tail pinch or other stressors have all been shown to increase striatal dopamine release and turnover in rodents14 and it has been suggested that this could excite striatal dopamine nerve terminals to death through increased oxidative stress.15
Chronic stress can lead to reduced dopaminergic activity within the ventral tegmental area in rodents16 and cause increased cortisol levels, and higher salivary cortisol levels compared with matched controls have been described in PD patients.17 In rats, chronic stress significantly decreased dopamine levels in the frontal cortex, striatum and the hippocampus.18
It is possible, however, that proneness to emotional stress might be the first sign of a neurodegenerative disease and changes in prefrontal, parietal or limbic networks lead to an impairment in coping with stressful life events.
Possible mechanisms underlying stress-induced neuronal degeneration
Stress reduces regulatory T-lymphocytes by 50% in patients who suffered from post-traumatic stress disorder19 and a similar profound reduction has been found in PD.20 Dysfunction of regulatory T-lymphocytes might contribute to dopaminergic cell loss and vaccination in animal models of PD with these regulatory lymphocytes can attenuate nigrostriatal degeneration.21
Chronic stress has been also found to induce the proinflammatory networks of cytokines and chemokines, which in turn activate the HPA axis.22 Upregulation of cytokines has been linked with sudden death after major emotional trauma23 and increased concentrations of tumour necrosis factor, interleukins and β 2 microglobulin have been reported in the substantia nigra of PD patients.24 Further, dysregulation of the HPA axis can cause dendritic remodelling, dysfunction of neurogenesis, apoptosis in hippocampal neurons and result in increased oxidative stress.11
Catecholamines such as dopamine are inert when stored in vesicles, but it is possible that in susceptible patients chronic stress shifts catecholamines into the cytosol where they become toxic via auto-oxidation. Oxidation of cathecholamines leads to quinones which can cause lipid peroxidation and membrane disruption25 and might ultimately cause neurodegeneration. Support for this hypothesis comes from additional preclinical studies, which have shown that chronic stress induces oxidative stress and increased protein and lipid peroxidation.26
Can emotional stress cause symptoms that resemble transient PD?
Sayings such as ‘shaking in fear’, ‘staring in disbelief’ or ‘frozen with fear’ exist in many languages and suggest that acute emotional stress can mimic some features of PD.
Dramatic examples of reversible parkinsonism were frequently reported among the casualties of ‘shell shock’ and ‘war neurosis’ that in Germany were referred to as ‘Kriegszitterer’ (‘War tremblers’). In the surviving cine films, most of these handicaps resembled a psychogenic movement disorder and suggestion therapy led to an improvement in most cases.27
A few cases, however, closely resembled PD (see online supplementary video) and neurologists described some World War I soldiers as follows: “The eyes were wide open and had a pained vacant stare. He cannot move his legs, which are rigid[…]. As in many of these patients the sole of the foot is shuffled along the ground. Another form of tremor which is coarser and less rapid than the preceding, viz. 5–6 per sec, is that which resembles paralysis agitans.”28 Others observed similar findings reporting “balance is maintained with difficulty since the trunk is flexed anteriorly and the legs are partially bent at the knees. The arms hang low and stiffly at the sides, giving a simian appearance to the whole posture. Coarse tremors develop in the hands and legs (…), the facies are mask-like without expression.”29
One of us (AJL) has looked after two women who were diagnosed with PD for several years, who were not depressed and who both fully recovered following the resolution of chronic stress. Both patients had asymmetrical bradykinesia and rigidity and their motor handicaps were not distractible. Onset in both cases was gradual and one patient was found to have a mildly abnormal fluorodopa positron emission tomography scan and responded well to L-dopa (see handwriting copies in figures 1 and 2). Once the chronic stressor disappeared, it was possible to discontinue dopaminergic medication in both patients with full and sustained recovery; iatrogenic, toxic or infectious causes were not identified in either case and there was no history of the use of neuroleptic or complementary therapies known to cause parkinsonism. One of the patients described here had no tremor and in the other case it was mild and could not be entrained.
It is, however, possible that these two patients both suffered from psychogenic parkinsonism.
Psychogenic parkinsonism is rare and it can occasionally be difficult to distinguish these cases from idiopathic PD. Characteristic features of psychogenic parkinsonism include abnormally slow and effortful movements without sequencing effect and normal speed of movement when distracted, exaggerated response to postural stability testing and an abrupt onset of the tremor with variable frequency.30 Although emotional stress often plays a precipitating role in maintaining psychogenic parkinsonism, many of these patients also have a somatoform or conversion disorder.30
These observations emphasise that prolonged chronic stress can induce a clinical picture closely resembling transient parkinsonism in susceptible individuals.
The phenomenon of kinesia paradoxica
“In acute life threatening incidents such as earthquakes31 or shipwrecks, PD patients can rarely, but spectacularly, override their often severe motor handicap.” We distinguish these striking cases induced by acute severe stressors from visual, musical and proprioceptive cueing improvements in gait. The following mechanisms have been postulated to explain paradoxical kinesia in PD:
Acute severe stress can lead to norepinephrine activation, which then increases alertness and attention and might result in improved motor function.32 Consistent with this, rats treated with haloperidol and showing motor impairments were able to overcome their motor deficits by stress-induced norepinephrine activation.32
Activation of basal ganglia reserves due to fear can also overcome bradykinesia. For example, PD patients off medication speed up in a decision-making task in an attempt to avoid painful electric shocks.33
While under these acute stressors motor performance improves, chronic anxiety and stress characteristically aggravate motor symptoms in PD, particularly rest tremor.16
Onset of PD is gradual and it is often difficult to determine when motor dysfunction begins. Ray Kennedy, the Arsenal and Liverpool English International football player described prominent mental and physical fatigue at least 14 years before the diagnosis of PD was made at the age of 35. He also described slow thinking, a general lack of energy and disturbances of temperature regulation. “I realised that nobody had my after match routine. Usually the adrenaline is still pumping and most of the lads would be talking about what happened on the pitch, grabbing a coke or chicken leg. They were always doing something-all except me. I used to slump hunched in my seat too tired to talk or move.”34
Non-specific non-motor symptoms can sometimes lead to the misdiagnoses of a functional disorder, especially in younger patients and may delay the correct diagnosis of PD for several decades.35 In fact, non-motor complaints were the initial presentation of 21% of pathologically proven PD.36 In this cohort, depression as a prodrome of PD was found in 2.5% with 25% developing these symptoms within the first 2 years.36
Recent papers have attempted to retrospectively examine the nature and frequency of these non-specific features before the diagnosis of PD. PD patients complained of more non-specific symptoms 10 years prior to the diagnosis of PD and visited their general practitioners (GPs) significantly more often than controls.37 ,38 A significantly higher frequency of medically unexplained symptoms has been associated with PD (7–7.5%) and PD patients with dementia (12–19%) than in other neurodegenerative diseases such as atypical parkinsonism or the primary dementias (0–3%). Musculoskeletal symptoms such as frozen shoulder was the initial complain in 8% of patients who developed PD up to 2 years later.39 Further, fibromyalgia, diarrhoea and autonomic dysfunction were also more frequently seen in pre-PD patients than controls.37 These results were in line with another study finding that hyposmia, constipation, disturbed sleep, depression, apathy, moodiness and increased sweating were the most frequently reported symptoms in the decade prior to the diagnosis of PD.40
One prospective study did not find a link between some psychosocial risk factors, such as major life events in childhood, major life events in adult life and the risk of PD. However, the authors speculated that other stressors such as accumulation of life events in work life, economic hardship and being somewhat socially isolated may be a risk factor for developing PD. Further, vital exhaustion defined as a psychological response reflecting a breakdown of the adaption to stress, including symptoms such as unusual fatigue, was significantly associated with the risk of developing PD.41
Clinical overlap between functional somatic symptoms and non-motor symptoms in PD
There is a striking overlap between the symptoms of chronic fatigue syndrome, fibromyalgia and irritable bowel syndrome, all classed as functional somatic syndromes (see online supplementary material) and the spectrum of non-motor symptoms seen in PD.
Mental fatigue, a typical feature of patients with chronic fatigue syndrome, can be found in up to 70% of PD patients at some stage of the illness.42
Gastrointestinal dysfunction has been described as the most common non-motor dysfunction in PD43 and typical features of irritable bowel syndrome such as abdominal bloating occur commonly in PD while abdominal colic can also occur.44 The long-term follow-up studies of the Honolulu–Asia Aging Study showed that constipation, a variant of irritable bowel syndrome associated with more abdominal pain and bloating than the diarrhoea variant,45 was associated with a higher risk of developing PD.46 Further, those who had constipation without PD had significantly lower substantia nigra neuronal densities and had more incidental Lewy body pathology in the substantia nigra.47 Braak and colleagues based on neuroanatomical studies in which they used Lewy bodies as a surrogate marker for nerve cell dysfunction have claimed that PD may begin much earlier in the enteric nervous system, sympathetic ganglia, olfactory bulb and medulla oblongata.48 Indeed, α-synuclein in colonic biopsy was found 2–5 years prior to the onset of motor symptoms49 and Lewy neurites have been also found on routine colonoscopies in 72% of PD patients, which correlated significantly with disease progression.50
Conversely, symptoms commonly reported in PD have been found in patients with somatic syndromes. Over 75% of patients with chronic fatigue complain of ‘slow thinking’,51 which can be an early feature of PD often referred to as bradyphrenia. Reduction in stride length, slowness of movements, impairment of flexing and bending knees and hips and trouble keeping up on treadmills can occur in patients with chronic fatigue syndrome.52
However, we do not suggest that chronic fatigue syndrome is a variant of PD, although there may be some overlap at a neural level in the mechanism of symptom expression. In contrast to PD, which is a chronic progressive degenerative disease with neuronal cell loss, chronic fatigue syndrome can be reversible with treatments such as cognitive behavioural therapy.53 ,54
Altered muscle synergy found in electromyography studies leading to stiffness and muscular fatigue has been also reported in patients with fibromyalgia, possibly due to striatal dysfunction.55 Restless legs syndrome, muscle and joint stiffness are frequently seen in patients with fibromyalgia.55 Tremor, stiffness and poor coordination56 and volumetric changes within the striatum have been reported.55 Musculoskeletal pain, unusual pelvic and rectal discomfort, poor sleep and fatigue, features characteristic for functional somatic syndromes, are common in PD.57 Depression is commonly seen in functional somatic syndromes58 and PD57 and can be triggered by emotional stress.3 Whether depression can contribute to the onset of PD is, however, unclear.3
Links between dopaminergic dysfunction and medically unexplained symptoms have been described (for further details, see online supplementary material).
We speculate that chronic emotional stress may cause dopaminergic cell loss in susceptible individuals and propose that functional somatic syndromes are commonly seen in patients with PD. Dopaminergic dysfunction with abnormalities in striato–thalamo–cortical brain circuits may be the shared underlying cause.
Implications for future research
Hypersensitivity to stress is thought to be genetically determined and can result in alterations of DNA methylation, which in turn regulates α-synuclein expression.60 Significant shortening of leucocyte telomeres has been found in individuals with a stressful life61 and shorter telomeres have been linked with PD in some62 but not all studies.63
Screening PD patients and patients with functional somatic syndromes for polymorphisms that are known to be important for stress regulation might prove to be one important future line of epigenetic research. Prospective long-term follow-up studies in the middle-aged population measuring stress hormones such as cortisol levels from hair, which has shown to be a valid biomarker for measuring the long-term cortisol secretion, and inflammatory markers such as T-lymphocytes is another potential line of future research that may further clarify the role of stress in PD. Finally, the roles of physical exercise and cognitive behavioural therapy in chronic stress reduction are worthy of further scientific examination.
We owe a huge debt of gratitude to Dr Alan Carson for his valuable advice. We also thank Professor Simon Wessely from the Maudsley Hospital for his helpful comments.
Contributors AJL and AD were equally involved in conception and design, or analysis and interpretation of data, drafting the article or revising it critically for important intellectual content and final approval of the version to be published.
Funding Reta Lila Weston Institute of Neurological Studies.
Competing interests None.
Provenance and peer review Not commissioned; externally peer reviewed.